Protocol Ledger

NCT04468529 · Phase III · COMPLETED

Evaluate the Effect of Injectable Neucardin on the Cardiac Function of Subjects With Chronic Systolic Heart Failure

Interventional Phase III clinical trial protocol NCT04468529 sponsored by Zensun Sci. & Tech. Co in Cardiovascular and Thrombosis, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2020-12-10 Enrollment: 154 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04468529
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)154 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)3 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04468529
Protocol FieldVerified Registry Value
NCT IdentifierNCT04468529
Consolidated Lead SponsorZensun Sci. & Tech. Co
Therapeutic Condition CohortCardiovascular and Thrombosis
Clinical Trial PhasePhase III
Overall Recruitment StatusCOMPLETED
Registered Enrollment154 participants (ACTUAL)
Registered Start Date2020-12-10
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT04468529
Hospital Research SiteLocationSite Profile
Chinese PLA General HospitalBeijing, ChinaOpen Hospital Dossier ->
The First Hospital of Jilin UniversityChangchun, ChinaOpen Hospital Dossier ->
The Second Xiangya Hospital of Central South UniversityChangsha, ChinaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI